Pharma Tariffs and Investment Commitments Under Trump's Policies
Commerce Secretary Howard Lutnick investigated under Section 232 for national security threats.
MFN agreements and onshoring companies face 0% tariffs through 2029, driving $400B investment.
Tariffs take effect in 120/180 days for large/small firms.
Generic drugs and biosimilars are exempt for one year.
UK has lower rates due to recent agreement; Japan, South Korea, Switzerland, EU have previous rates.
1 week ago